Cargando…
Mucinous borderline ovarian tumors with BRAF(V600E) mutation may have low risk for progression to invasive carcinomas
PURPOSE: Mucinous ovarian carcinomas (MOCs) are relatively rare. It has been proposed that a subset of mucinous cystadenomas (MCAs) may progress to mucinous borderline tumors (MBTs), and then to MOCs. KRAS is the predominantly mutated gene in MOC; however, other associated mutations and the mechanis...
Autores principales: | Ohnishi, Kaori, Nakayama, Kentaro, Ishikawa, Masako, Ishibashi, Tomoka, Yamashita, Hitomi, Nakamura, Kohei, Minamoto, Toshiko, Iida, Kouji, Razia, Sultana, Ishikawa, Noriyoshi, Kyo, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321901/ https://www.ncbi.nlm.nih.gov/pubmed/32556513 http://dx.doi.org/10.1007/s00404-020-05638-8 |
Ejemplares similares
-
High PD-1 expression level is associated with an unfavorable prognosis in patients with cervical adenocarcinoma
por: Ishikawa, Masako, et al.
Publicado: (2020) -
KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
por: Nakamura, Kohei, et al.
Publicado: (2016) -
Genetic analysis and phosphoinositide 3-kinase/protein kinase B signaling pathway status in ovarian endometrioid borderline tumor samples
por: Nakamura, Kohei, et al.
Publicado: (2018) -
Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients
por: Ishikawa, Masako, et al.
Publicado: (2018) -
Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
por: Yamashita, Hitomi, et al.
Publicado: (2017)